Miltenyi Biotec
↗Bergisch Gladbach, Germany
Miltenyi Biotec is a global leader in the field of cell processing and cell therapy, providing a comprehensive range of products and services for biomedical research and clinical applications. Founded in 1989, the company is best known for its pioneering Magnetic-Activated Cell Sorting (MACS) technology, which has become a standard in laboratories worldwide for isolating specific cell types from complex mixtures.
The company operates across the entire workflow of cell and gene therapy (CGT), from basic research and sample preparation to large-scale clinical manufacturing. Through its subsidiaries like Miltenyi Biomedicine and Miltenyi Bioindustry, it develops proprietary CAR-T cell therapies and provides CDMO services, including lentiviral vector (LVV) production and automated cell processing using the CliniMACS Prodigy platform.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Cell and Gene Therapy (CGT)
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$1B+
Founded:1989
Ownership:private
Status:operating
FUNDING
Stage:Private Debt Financed
Investors:Stefan Miltenyi (100% owner), Deutsche Bank (Lender)
PIPELINE
Stage:Commercial
Lead Drug Stage:Phase 2 (Pivotal)
Modalities:Cell therapy, Gene therapy, CAR-T, TCR-T, mAb, Lentiviral vectors
Active Trials:12
Trial Phases:Phase 1: 5 | Phase 2: 4
FDA Approvals:1
EMA Approvals:1
CORPORATE STRUCTURE
Subsidiaries:Miltenyi Biomedicine GmbH, Miltenyi Bioindustry, Lentigen Technology Inc., Lino Biotech AG, Miltenyi Biotec K.K. (Japan)
Key Partnerships:Immatics (LVV supply for anzu-cel), Verismo Therapeutics (Clinical program support), Autolus Therapeutics (CliniMACS platform for AUCATZYL), Adaptimmune (LVV manufacture for TECELRA), BIRAC India (CGT ecosystem development)
COMPETITION
Position:Leader
Competitors:Danaher (Cytiva/Pall), Thermo Fisher Scientific, Lonza, Sartorius, Becton Dickinson (BD), Terumo Blood and Cell Technologies
LEADERSHIP
Key Executives:
Stefan Miltenyi - Founder & President
Norbert Hentschel - Chief Financial Officer
Toon Overstijns - Chairman of the Board, Miltenyi Biomedicine
Scientific Founders:Stefan Miltenyi
Board Members:Dr. Boris Stoffel, Dr. Jürgen Schmitz, Dr. Antoon Overstijns
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Miltenyi Biotec. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.